LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 1401 | 1864 | 3978 | 0.4685 | 0.2086 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 1401 | 2298 | 4213 | 0.5454 | 0.3653 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 1401 | 2310 | 4545 | 0.5082 | 0.3423 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 1401 | 1325 | 4139 | 0.3201 | -0.0353 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 1401 | 1327 | 4095 | 0.3240 | -0.0347 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 1401 | 1223 | 4272 | 0.2863 | -0.0812 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 1401 | 1512 | 3978 | 0.3800 | 0.0517 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 1401 | 1589 | 4213 | 0.3771 | 0.0823 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 1401 | 1476 | 4545 | 0.3247 | 0.0310 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 1401 | 1100 | 4139 | 0.2658 | -0.1436 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 1401 | 871 | 4095 | 0.2127 | -0.2647 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 1401 | 986 | 4272 | 0.2308 | -0.1964 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 1401 | 902 | 3978 | 0.2267 | -0.2538 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 1401 | 972 | 4213 | 0.2307 | -0.2058 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 1401 | 921 | 4545 | 0.2026 | -0.2191 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 1 | G13 | 72 | hr | 1401 | 1261 | 4139 | 0.3047 | -0.0654 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 2 | G13 | 72 | hr | 1401 | 1021 | 4095 | 0.2493 | -0.1852 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 3 | G13 | 72 | hr | 1401 | 1178 | 4272 | 0.2757 | -0.1024 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 1 | G13 | 72 | hr | 1401 | 1080 | 3978 | 0.2715 | -0.1590 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 2 | G13 | 72 | hr | 1401 | 1006 | 4213 | 0.2388 | -0.1885 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 3 | G13 | 72 | hr | 1401 | 968 | 4545 | 0.2129 | -0.1959 |
| SK-BR-3 | uM | LJP6 | 1 | A03 | 72 | hr | 1401 | 3375 | 4139 | 0.8154 | 0.7551 | ||
| SK-BR-3 | uM | LJP6 | 1 | A04 | 72 | hr | 1401 | 3394 | 4139 | 0.8200 | 0.7614 | ||
| SK-BR-3 | uM | LJP6 | 1 | A05 | 72 | hr | 1401 | 3832 | 4139 | 0.9258 | 0.9037 | ||
| SK-BR-3 | uM | LJP6 | 1 | A06 | 72 | hr | 1401 | 3458 | 4139 | 0.8355 | 0.7826 |